BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36729766)

  • 1. Peritoneal Mesothelioma-An Update.
    Malpica A
    Adv Anat Pathol; 2023 Jul; 30(4):262-274. PubMed ID: 36729766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.
    Desmeules P; Joubert P; Zhang L; Al-Ahmadie HA; Fletcher CD; Vakiani E; Delair DF; Rekhtman N; Ladanyi M; Travis WD; Antonescu CR
    Am J Surg Pathol; 2017 Jul; 41(7):980-988. PubMed ID: 28505004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.
    Hung YP; Dong F; Watkins JC; Nardi V; Bueno R; Dal Cin P; Godleski JJ; Crum CP; Chirieac LR
    JAMA Oncol; 2018 Feb; 4(2):235-238. PubMed ID: 28910456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
    Dermawan JK; Torrence D; Lee CH; Villafania L; Mullaney KA; DiNapoli S; Sukhadia P; Benayed R; Borsu L; Agaram NP; Nash GM; Dickson BC; Benhamida J; Antonescu CR
    Genes Chromosomes Cancer; 2022 Oct; 61(10):592-602. PubMed ID: 35665561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.
    Dietz MV; van Kooten JP; Paats MS; Aerts JGVJ; Verhoef C; Madsen EVE; Dubbink HJ; von der Thüsen JH
    ESMO Open; 2023 Aug; 8(4):101600. PubMed ID: 37453150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal mesothelioma: the site of origin matters.
    Kindler HL
    Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
    Singhi AD; Krasinskas AM; Choudry HA; Bartlett DL; Pingpank JF; Zeh HJ; Luvison A; Fuhrer K; Bahary N; Seethala RR; Dacic S
    Mod Pathol; 2016 Jan; 29(1):14-24. PubMed ID: 26493618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma.
    Glass C; Sholl LM; Landgraf JR; Chirieac L; Roggli VL
    Am J Surg Pathol; 2020 Feb; 44(2):288-292. PubMed ID: 31567203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation.
    Berger Y; Gadiraju M; Dhiman A; Gilliam K; Opalecky B; Chen H; Helgeson M; Eng OS; Husain AN; Drazer MW; Kindler HL; Churpek JE; Turaga KK
    Cancer; 2023 Jul; 129(14):2152-2160. PubMed ID: 37042570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology.
    Agaimy A; Brcic L; Briski LM; Hung YP; Michal M; Michal M; Nielsen GP; Stoehr R; Rosenberg AE
    Genes Chromosomes Cancer; 2023 May; 62(5):256-266. PubMed ID: 36524687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.
    Stevers M; Rabban JT; Garg K; Van Ziffle J; Onodera C; Grenert JP; Yeh I; Bastian BC; Zaloudek C; Solomon DA
    Mod Pathol; 2019 Jan; 32(1):88-99. PubMed ID: 30171198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.
    van Kooten JP; Dietz MV; Dubbink HJ; Verhoef C; Aerts JGJV; Madsen EVE; von der Thüsen JH
    Clin Exp Med; 2024 Apr; 24(1):80. PubMed ID: 38642130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases.
    Malpica A; Euscher ED; Marques-Piubelli ML; Ferrufino-Schmidt MC; Miranda RN; Sams R; Royal RE; Raghav KPS; Fournier KF; Ramalingam P
    Am J Surg Pathol; 2021 Jan; 45(1):45-58. PubMed ID: 32769428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
    Shrestha R; Nabavi N; Lin YY; Mo F; Anderson S; Volik S; Adomat HH; Lin D; Xue H; Dong X; Shukin R; Bell RH; McConeghy B; Haegert A; Brahmbhatt S; Li E; Oo HZ; Hurtado-Coll A; Fazli L; Zhou J; McConnell Y; McCart A; Lowy A; Morin GB; Chen T; Daugaard M; Sahinalp SC; Hach F; Le Bihan S; Gleave ME; Wang Y; Churg A; Collins CC
    Genome Med; 2019 Feb; 11(1):8. PubMed ID: 30777124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.
    Alakus H; Yost SE; Woo B; French R; Lin GY; Jepsen K; Frazer KA; Lowy AM; Harismendy O
    J Transl Med; 2015 Apr; 13():122. PubMed ID: 25889843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.
    Kittaneh M; Berkelhammer C
    J Transl Med; 2018 Jul; 16(1):194. PubMed ID: 30001711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma.
    Brich S; Bozzi F; Perrone F; Tamborini E; Cabras AD; Deraco M; Stacchiotti S; Dagrada GP; Pilotti S
    Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
    Baumann F; Flores E; Napolitano A; Kanodia S; Taioli E; Pass H; Yang H; Carbone M
    Carcinogenesis; 2015 Jan; 36(1):76-81. PubMed ID: 25380601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of malignant peritoneal mesothelioma without deletion of p16].
    Kubo N; Wajima N; Kimura A; Akasaka H; Sakuraba S; Yamana D; Nagase H; Ichinohe D; Hakamada K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2487-9. PubMed ID: 25731566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy.
    Sugarbaker PH; Turaga KK; Alexander HR; Deraco M; Hesdorffer M
    J Oncol Pract; 2016 Oct; 12(10):928-935. PubMed ID: 27858561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.